Brief: Biosynex FY Revenue Up At EUR 382.7 Mln
Jan 20 (Reuters) - BIOSYNEX SA ALBIO.PA :
* FY REVENUE EUR 382.7 MILLION VERSUS EUR 153.9 MILLION YEAR
AGO
* 2021 RESULTS EXPECTED IN STRONG GROWTH
* REBOUND IN SALES AT THE END OF THE YEAR
* ANTICIPATES SUSTAINED GROWTH IN ITS OPERATING
PROFITABILITY
INDICATORS FOR FISCAL YEAR 2021, DRIVEN BY ITS DYNAMIC SALES
Source text for Eikon: ID:nEQ9V9M1La
Further company coverage: ALBIO.PA
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Biosynex SA
See all newsBrief: Biosynex FY Revenue Down To EUR 93.1 Million
Brief: Biosynex Announces Completion Of Merger-Absorption Of Theradiag
Brief: Biosynex Q3 Group Revenue Rises To EUR 24.4 Mln
Brief: Biosynex Announces Its Subsidiary Procisedx Acquires Two U.S. Patents
Brief: Biosynex's Procisedx Obtains First FDA Approvals